Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07730840) titled 'Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke' on July 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Asan Medical Center
Condition:
Ischemic Stroke
Transient Ischemic Attack
Intervention:
Drug: Zastaprazan
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 15, 2026
Target Sample Size: 984
Countries of Recruitment:
South Korea
To know more, visit https://clin...